Has Warren Hill, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,143,909 in general payments to Warren Hill, MD across 135 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Warren Hill, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Warren Hill, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Warren Hill, MD

Ophthalmology · Mesa, AZNPI 1104990506

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $932,245 of the $1,143,909 with a category attached, or 81.5%. Haag-streit USA, Inc. accounts for 69.5% of it on its own, with 13 other manufacturers making up the rest. Among ophthalmology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,143,909in general payments, 2019–2025

Across 135 payments — averaging $8473.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Haag-streit USA, Inc.$795K
Alcon$223K
Alcon Research LLC$105K
Carl Zeiss Meditec, Inc.$10K
Rxsight Inc$5K
Lensar, Inc.$5K
plus $1K from 8 others

$38,450in research payments, 2019–2025

Across 2 payments — averaging $19,225 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Lensar, Inc.$38K

What the payments were for

Royalty or licence$180,00016%
Consulting fees$932,24581%
Speaking & faculty fees$12,3791%
Travel & lodging$16,2711%
Food & beverage$2,9420%
Gifts$720%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Haag-streit USA, Inc.	30	$795,459
Alcon	38	$222,767
Alcon Research LLC	41	$104,707
Carl Zeiss Meditec, Inc.	7	$10,222
Rxsight Inc	2	$5,029
Lensar, Inc.	4	$4,641
Carl Zeiss Meditec Digital Innovations LLC	4	$557
Bausch & Lomb, A Division Of Bausch Health US, LLC	2	$231
Genentech, Inc.	1	$128
Johnson & Johnson Surgical Vision, Inc.	2	$74
Bausch & Lomb Americas Inc.	1	$47
Carl Zeiss Meditec AG	1	$19
Novartis	1	$15
Eyepoint US, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AcrySof$135,965
Clareon$78,600
AcrySof IQ PanOptix$37,275
Verion$16,982
ORA$12,775
FORUM$9,100
RXSIGHT CONTACT LENS$5,000
RXSIGHT INJECTOR CARTRIDGE$5,000
RXSIGHT INJECTOR HANDPIECE$5,000
RXSIGHT LIGHT DELIVERY DEVICE (LDD)$5,000
LIGHT ADJUSTABLE LENS (LAL)$5,000
LENSAR LASER SYSTEM$4,609
UltraSert$2,450
Clareon Autonome IOL Injector$2,450
VERACITY SURGICAL$523
STELLARIS$160
Lucentis$128
IOLMaster 500$117

How this compares

$1,143,909 in reported general payments places this provider in the 95th percentile of 310 ophthalmology providers in Arizona.

See all ophthalmology providers in Arizona →

Medicare billing

Part B allowed, 2024

$56,155

Medicare patients

235

Services billed

797

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol	15	$2,577
Latanoprost	129	$2,013
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	45	$1,114

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Mesa

Derek KunimotoMesa$138K
Yuri McKeeMesa$100K
Mark BarakatScottsdale$794K
Anne ZakiSun City West$518K
Pravin DugelPhoenix$176K
Shamil PatelGlendale$116K
Nishi ShahPhoenix$92K
Lisa MihoraPeoria$91K
George ReissGlendale$73K
Wendy HuangGlendale$73K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →